UMB Bank n.a. boosted its position in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 38.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 964 shares of the electronics maker’s stock after acquiring an additional 266 shares during the quarter. UMB Bank n.a.’s holdings in Dolby Laboratories were worth $72,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC grew its stake in shares of Dolby Laboratories by 114.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,141 shares of the electronics maker’s stock valued at $975,000 after buying an additional 6,484 shares during the last quarter. Park Avenue Securities LLC purchased a new position in Dolby Laboratories during the 1st quarter valued at $222,000. Vanguard Group Inc. boosted its holdings in Dolby Laboratories by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock valued at $605,194,000 after acquiring an additional 502,110 shares during the period. Fiera Capital Corp increased its stake in Dolby Laboratories by 19.0% in the first quarter. Fiera Capital Corp now owns 639,404 shares of the electronics maker’s stock worth $51,351,000 after purchasing an additional 102,028 shares during the period. Finally, Principal Financial Group Inc. increased its stake in Dolby Laboratories by 3.0% in the first quarter. Principal Financial Group Inc. now owns 140,806 shares of the electronics maker’s stock worth $11,308,000 after purchasing an additional 4,121 shares during the period. Institutional investors own 58.56% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the stock. Barrington Research reissued an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 12th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Rosenblatt Securities reaffirmed a “buy” rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Finally, Tigress Financial increased their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.75.
Dolby Laboratories Stock Performance
Shares of DLB opened at $71.43 on Friday. The company has a 50 day moving average price of $73.13 and a 200-day moving average price of $74.91. Dolby Laboratories has a fifty-two week low of $68.24 and a fifty-two week high of $89.66. The stock has a market capitalization of $6.85 billion, a PE ratio of 26.17 and a beta of 0.93.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to analyst estimates of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.Dolby Laboratories’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Equities research analysts forecast that Dolby Laboratories will post 2.94 EPS for the current year.
Dolby Laboratories Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s payout ratio is 48.35%.
Insider Activity
In other news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the transaction, the senior vice president owned 70,435 shares of the company’s stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of the business’s stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at approximately $8,583,724.50. This trade represents a 25.79% decrease in their position. The disclosure for this sale can be found here. Insiders sold 99,366 shares of company stock worth $7,293,963 in the last quarter. 38.39% of the stock is owned by insiders.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- 5 Top Rated Dividend Stocks to Consider
- Lower Rates Put RV Stocks Back in the Fast Lane
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Alphabet: Time to Take Profits, Buy, or Wait for a Pullback?
- Quiet Period Expirations Explained
- Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.